Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | HPGDS | O60760 | 3/20 | 0.32 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12142021 | 0.90 | HPGDS (0.35) | CNR2HPGDSC5AR1ACHE | |
| SCHEMBL12143781 | 0.74 | TP53 (0.44) | HPGDS | |
| SCHEMBL18987897 | 0.73 | HPGDS (0.36) | HPGDSC5AR1 | |
| SCHEMBL24126984 | 0.72 | TSHR (0.37) | ACHE | |
| Hydrochloric Acid SCHEMBL18987997 | 0.71 | HPGDS (0.35) | HPGDSC5AR1 | |
| SCHEMBL24126973 | 0.71 | ALDH1A1 (0.38) | ACHE | |
| SCHEMBL24126734 | 0.71 | ALDH1A1 (0.35) | CNR2ACHE | |
| SCHEMBL3000001 | 0.69 | ALDH1A1 (0.35) | HPGDSC5AR1 | |
| SCHEMBL3524051 | 0.67 | MAPT (0.38) | CNR2HPGDS | |
| SCHEMBL4394130 | 0.65 | HPGDS (0.50) | HPGDS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230339937-A1 | CONDENSED RING COMPOUNDS THAT INHIBIT H-PGDS | SATO PHARMACEUTICAL CO., LTD. (JP) | 2023-10-26 | — | — | US | disclosed |
| US-20230339937-A1 | CONDENSED RING COMPOUNDS THAT INHIBIT H-PGDS | SATO PHARMACEUTICAL CO., LTD. (JP) | 2023-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230339937-A1 | CONDENSED RING COMPOUNDS THAT INHIBIT H-PGDS | HPGDS, PTGS1, PTGIS | CNR2 634/4885HPGDS 1/4885C5AR1 2518/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.